Moxetumomab pasudotox and Nuvakaan
Determining the interaction of Moxetumomab pasudotox and Nuvakaan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: lidocaine / prilocaine topical
Brand name: Emla, Emla Anesthetic Disc, Livixil Pak, AgonEaze, Prizopak, LiproZonePak, Medolor Pak, Anodyne LPT
Synonyms: Lidocaine and prilocaine topical, Lidocaine and Prilocaine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-NuvaRing
- Moxetumomab pasudotox-Nuvessa
- Moxetumomab pasudotox-Nuvigil
- Moxetumomab pasudotox-Nuwiq (Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS))
- Moxetumomab pasudotox-Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))
- Moxetumomab pasudotox-Nuwiq recombinant
- Nuvakaan-Moxetumomab Pasudotox-tdfk
- Nuvakaan-Moxetumomab pasudotox-tdfk Intravenous
- Nuvakaan-Moxifloxacin
- Nuvakaan-Moxifloxacin (Systemic)
- Nuvakaan-Moxifloxacin Hydrochloride
- Nuvakaan-Moxifloxacin Injection